Home › NDC Lookup › RxCUI directory › RxCUI 403879

Imatinib 400 MG Oral Tablet — RxCUI 403879

RxNorm drug concept · Semantic clinical drug
RxCUI 403879 Semantic clinical drug · SCD ● Current RxNorm concept 42 FDA products 66 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI403879
Official nameImatinib 400 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asimatinib (as imatinib mesylate) 400 MG Oral Tablet; imatinib mesylate 400 MG Oral Tablet
FDA products mapped42
Package NDCs mapped66
Reported Medicaid activity (SDUD)12,484 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Imatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Imatinib targets specific proteins that are driving your cancer cells to grow out of control. In leukemias like CML, it blocks a faulty protein called BCR-ABL that results from a g...
  • What exactly is imatinib treating in my body?
  • Yes — always take imatinib with a meal and a large glass of water. Taking it on an empty stomach increases the chance of nausea and stomach irritation. If you're taking the tablet...
  • Does it matter when I take it or whether I eat first?
📖 Read our full Imatinib guide →

🕸️ Concept Web — How Imatinib 400 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Imatinib 400 MG Oral Tablet RxCUI 403879

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Imatinib 282388
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gleevec 282386
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Imatinib Oral Tablet 406050
    • Imatinib Oral Product 1160679
    • Imatinib Pill 1160680
    • Imatinib Oral Tablet [Gleevec] 406060
    • Gleevec Oral Product 1171230
    • Gleevec Pill 1171231
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Imatinib 400 MG SCDC · 406051
  • Imatinib Oral Tablet SCDF · 406050
  • Imatinib Oral Product SCDG · 1160679
  • Imatinib Pill SCDG · 1160680

Brand-Name Concepts

  • Imatinib 400 MG Oral Tablet [Gleevec] SBD · 404589
  • Imatinib 400 MG [Gleevec] SBDC · 576514
  • Imatinib Oral Tablet [Gleevec] SBDF · 406060
  • Gleevec Oral Product SBDG · 1171230
  • Gleevec Pill SBDG · 1171231
  • Gleevec BN · 282386

📦 FDA Products & Package NDCs

42 products · 66 package NDCs
66 package NDCs map to RxCUI 403879 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00078-0401-34 90 TABLET in 1 BOTTLE (0078-0401-34) Gleevec Novartis Pharmaceuticals Corporation 2001-05-15
00078-0649-13 3 BLISTER PACK in 1 CARTON (0078-0649-13) / 10 TABLET in 1... Gleevec Novartis Pharmaceuticals Corporation 2024-03-01
00078-0649-30 30 TABLET in 1 BOX, UNIT-DOSE (0078-0649-30) Gleevec Novartis Pharmaceuticals Corporation 2014-12-23
00078-1490-13 3 BLISTER PACK in 1 CARTON (0078-1490-13) / 10 TABLET in 1... Gleevec Novartis Pharmaceuticals Corporation 2025-12-20
00093-7629-98 90 TABLET, FILM COATED in 1 BOTTLE (0093-7629-98) Imatinib Mesylate Teva Pharmaceuticals USA, Inc. 2016-08-04
00093-7630-56 30 TABLET, FILM COATED in 1 BOTTLE (0093-7630-56) Imatinib Mesylate Teva Pharmaceuticals USA, Inc. 2016-08-04
00378-2245-77 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2245-77) Imatinib Mesylate Mylan Pharmaceuticals Inc. 2017-09-28
00378-2246-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2246-93) Imatinib Mesylate Mylan Pharmaceuticals Inc. 2017-09-28
00832-0532-09 90 TABLET in 1 BOTTLE (0832-0532-09) imatinib mesylate Upsher-Smith Laboratories, LLC 2024-05-17
00832-0533-03 30 TABLET in 1 BOTTLE (0832-0533-03) imatinib mesylate Upsher-Smith Laboratories, LLC 2024-05-17
00904-6621-04 30 BLISTER PACK in 1 CARTON (0904-6621-04) / 1 TABLET, FILM... Imatinib Mesylate Major Pharmaceuticals 2016-08-05
00904-6901-04 30 BLISTER PACK in 1 CARTON (0904-6901-04) / 1 TABLET, FILM... Imatinib Mesylate Major Pharmaceuticals 2016-08-05
31722-0296-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-296-90) IMATINIB MESYLATE Camber Pharmaceuticals, Inc. 2025-04-14
31722-0297-30 30 TABLET, FILM COATED in 1 BOTTLE (31722-297-30) IMATINIB MESYLATE Camber Pharmaceuticals, Inc. 2025-04-14
42292-0043-03 30 BLISTER PACK in 1 CARTON (42292-043-03) / 1 TABLET, FILM... Imatinib Mesylate Mylan Institutional Inc 2017-09-07
42292-0044-03 30 BLISTER PACK in 1 CARTON (42292-044-03) / 1 TABLET, FILM... Imatinib Mesylate Mylan Institutional Inc 2017-09-07
43598-0344-10 1000 TABLET in 1 CONTAINER (43598-344-10) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
43598-0344-30 30 TABLET in 1 CONTAINER (43598-344-30) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
43598-0344-31 3 BLISTER PACK in 1 CARTON (43598-344-31) / 10 TABLET in 1... Imatinib Dr.Reddy's Laboratories Inc 2020-09-15
43598-0344-90 90 TABLET in 1 CONTAINER (43598-344-90) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
43598-0345-05 500 TABLET in 1 CONTAINER (43598-345-05) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
43598-0345-30 30 TABLET in 1 CONTAINER (43598-345-30) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
43598-0345-31 3 BLISTER PACK in 1 CARTON (43598-345-31) / 10 TABLET in 1... Imatinib Dr.Reddy's Laboratories Inc 2020-09-15
43598-0345-90 90 TABLET in 1 CONTAINER (43598-345-90) Imatinib Dr.Reddy's Laboratories Inc 2018-08-13
47335-0472-13 500 TABLET, FILM COATED in 1 BOTTLE (47335-472-13) imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
47335-0472-83 30 TABLET, FILM COATED in 1 BOTTLE (47335-472-83) imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
47335-0472-88 100 TABLET, FILM COATED in 1 BOTTLE (47335-472-88) imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
47335-0475-13 500 TABLET, FILM COATED in 1 BOTTLE (47335-475-13) imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
47335-0475-64 3 BLISTER PACK in 1 CARTON (47335-475-64) / 10 TABLET, FILM... imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
47335-0475-88 100 TABLET, FILM COATED in 1 BOTTLE (47335-475-88) imatinib mesylate Sun Pharmaceutical Industries, Inc. 2016-02-01
48433-0049-03 30 BLISTER PACK in 1 CARTON (48433-049-03) / 1 TABLET, FILM... Imatinib Mesylate Safecor Health, LLC 2026-04-10
48433-0050-03 30 BLISTER PACK in 1 CARTON (48433-050-03) / 1 TABLET, FILM... Imatinib Mesylate Safecor Health, LLC 2026-04-10
51407-0269-90 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-269-90) Imatinib Mesylate Golden State Medical Supply, Inc. 2019-08-21
51407-0270-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-270-30) Imatinib Mesylate Golden State Medical Supply, Inc. 2019-08-21
59651-0240-90 90 TABLET, FILM COATED in 1 BOTTLE (59651-240-90) Imatinib Mesylate Aurobindo Pharma Limited 2020-07-23
59651-0241-03 3 BLISTER PACK in 1 CARTON (59651-241-03) / 10 TABLET, FILM... Imatinib Mesylate Aurobindo Pharma Limited 2020-07-23
59651-0241-30 30 TABLET, FILM COATED in 1 BOTTLE (59651-241-30) Imatinib Mesylate Aurobindo Pharma Limited 2020-07-23
60505-2900-00 10 BLISTER PACK in 1 CARTON (60505-2900-0) / 10 TABLET, FIL... Imatinib Mesylate Apotex Corp 2016-08-05
60505-2900-01 100 TABLET, FILM COATED in 1 BOTTLE (60505-2900-1) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2900-03 30 TABLET, FILM COATED in 1 BOTTLE (60505-2900-3) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2900-08 1000 TABLET, FILM COATED in 1 BOTTLE (60505-2900-8) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2900-09 90 TABLET, FILM COATED in 1 BOTTLE (60505-2900-9) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2901-00 10 BLISTER PACK in 1 CARTON (60505-2901-0) / 10 TABLET, FIL... Imatinib Mesylate Apotex Corp 2016-08-05
60505-2901-01 100 TABLET, FILM COATED in 1 BOTTLE (60505-2901-1) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2901-03 30 TABLET, FILM COATED in 1 BOTTLE (60505-2901-3) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2901-05 500 TABLET, FILM COATED in 1 BOTTLE (60505-2901-5) Imatinib Mesylate Apotex Corp 2016-08-05
60505-2901-09 90 TABLET, FILM COATED in 1 BOTTLE (60505-2901-9) Imatinib Mesylate Apotex Corp 2016-08-05
62135-0658-90 90 TABLET, FILM COATED in 1 BOTTLE (62135-658-90) Imatinib Mesylate Chartwell RX, LLC 2024-02-28
62135-0659-30 30 TABLET, FILM COATED in 1 BOTTLE (62135-659-30) Imatinib Mesylate Chartwell RX, LLC 2024-02-28
67184-0532-01 90 TABLET in 1 BOTTLE (67184-0532-1) imatinib mesylate Qilu Pharmaceutical Co., Ltd. 2022-06-21
Observed labelers: Apotex Corp (10) · Dr.Reddy's Laboratories Inc (8) · Qilu Pharmaceutical Co., Ltd. (6) · Sun Pharmaceutical Industries, Inc. (6) · BluePoint Laboratories (4) · Novartis Pharmaceuticals Corporation (4) · +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.